Discovery of Icotinib-1,2,3-Triazole Derivatives as IDO1 Inhibitors

Cited by papers we hold 2

• Triazoles and Their Derivatives: Chemistry, Synthesis, and Therapeutic Applications · 2022
  No notice
• Globally Approved EGFR Inhibitors: Insights into Their Syntheses, Target Kinases, Biological Activities, Receptor Interactions, and Metabolism · 2021
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.